Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Dexamethasone palmitate is a prodrug form of the synthetic glucocorticoid dexamethasone (Item No. 11015).1 It binds to the glucocorticoid receptor.2 Dexamethasone palmitate-containing lipid nanoparticles reduce LPS-induced increases in cytokine levels in RAW 264.7 macrophages when used at a concentration of 100 µg/ml.3 Dexamethasone palmitate reduces paw inflammation and edema in a mouse model of collagen-induced rheumatoid arthritis when administered at a dose of 1 mg/kg. Intravitreal injection of a dexamethasone palmitate (1,280 µg/animal) emulsion inhibits vascular hyperpermeability induced by VEGF for up to nine months in rabbits.1
WARNING This product is not for human or veterinary use.
1. A preliminary evaluation of dexamethasone palmitate emulsion: A novel intravitreal sustained delivery of corticosteroid for treatment of macular edema. J. Ocul. Pharmacol. Ther. 29(2), 258-269 (2013).
2. 17β-
3. Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis. J. Control. Release 296, 179-189 (2019).